VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy—A Message from COMET, a French Unicancer Multicentric Study

The prospective multicenter COMET trial followed a cohort of 306 consecutive metastatic breast cancer patients receiving bevacizumab and paclitaxel as first-line chemotherapy. This study was intended to identify and validate reliable biomarkers to better predict bevacizumab treatment outcomes and al...

Descripción completa

Detalles Bibliográficos
Autores principales: Gal, Jocelyn, Milano, Gérard, Brest, Patrick, Ebran, Nathalie, Gilhodes, Julia, Llorca, Laurence, Dubot, Coraline, Romieu, Gilles, Desmoulins, Isabelle, Brain, Etienne, Goncalves, Anthony, Ferrero, Jean-Marc, Cottu, Paul-Henri, Debled, Marc, Tredan, Olivier, Chamorey, Emmanuel, Merlano, Marco Carlo, Lemonnier, Jérôme, Etienne-Grimaldi, Marie-Christine, Pierga, Jean-Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700430/
https://www.ncbi.nlm.nih.gov/pubmed/33238394
http://dx.doi.org/10.3390/ph13110414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700430/
https://www.ncbi.nlm.nih.gov/pubmed/33238394
http://dx.doi.org/10.3390/ph13110414

Ejemplares similares